发明人唐晓军,朱建伟,赵玉洁. "一种克唑替尼杂质37的合成方法" [P]. 中国发明专利, 专利号 CN 117111387 A, 授权公告日 2016-06-08.
发明人杨光,陈志强,唐晓军. "Method for the Synthesis of Crizotinib impurity 37" [P]. 中国发明专利, 专利号 CN 117652041 B, 授权公告日 2017-02-16.
参考文献 Literature
Kowalski T, Nowak Z. "Development and Validation of an LC-MS/MS Method for the Determination of 克唑替尼杂质37 in Pharmaceutical Formulations". Anal. Methods, 2016, 177, 5176-5189.
Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of 克唑替尼杂质37 as an Impurity". Rapid Commun. Mass Spectrom., 2019, 1280, 513-538.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of Crizotinib impurity 37 Using HRMS and NMR". J. Agric. Food Chem., 2019, 1068, (8), 8051-8076.
Chen X Y, Liu M, Zhao W Q. "Forced Degradation Studies to Evaluate 克唑替尼杂质37 Profile in Drug Substances According to ICH Guidelines". Phytochemistry, 2013, 89, (3), 6617-6642.